Drug
nogapendekin alfa inbakicept-pmln
Marketed as ANKTIVA.
Generic name
nogapendekin alfa inbakicept-pmln
Brand names
ANKTIVA
First FDA approval
2024-04-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761336 | ANKTIVA | 2024-04-22 | ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU |
Manufacturers
ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
Frequently asked questions
When was nogapendekin alfa inbakicept-pmln FDA approved?
Earliest FDA approval on record: 2024-04-22.
What brand names are sold as nogapendekin alfa inbakicept-pmln?
ANKTIVA.
Sources
Appeal a nogapendekin alfa inbakicept-pmln denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com